Fin Trust Capital Advisors, LLC Crispr Therapeutics Ag Transaction History

Fin Trust Capital Advisors, LLC

$577 Million
Q3 2024

A detailed history of Fin Trust Capital Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 180 shares of CRSP stock, worth $8,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares

180

Previous 180 -0.0%

Holding current value

$8,623

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$45.39 - $59.0 $17,112 - $22,243	-377 Reduced 67.68%	180 $8,000
Q3 2022 Oct 20, 2022	SELL	$61.1 - $83.78 $24,562 - $33,679	-402 Reduced 41.92%	557 $32,000
Q1 2022 May 03, 2022	SELL	$53.19 - $79.24 $1.44 Million - $2.14 Million	-26,984 Reduced 96.57%	959 $60,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $151,464 - $240,497	2,161 Added 8.38%	27,943 $2.12 Million
Q3 2021 Nov 16, 2021	SELL	$110.2 - $156.64 $23,142 - $32,894	-210 Reduced 0.81%	25,782 $2.89 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $116,873 - $187,630	1,159 Added 4.67%	25,992 $4.21 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $43,845 - $83,175	-396 Reduced 1.57%	24,833 $3.03 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $63,815 - $138,757	801 Added 3.28%	25,229 $3.86 Million
Q3 2020 Nov 10, 2020	SELL	$78.5 - $100.64 $135,098 - $173,201	-1,721 Reduced 6.58%	24,428 $2.04 Million
Q2 2020 Sep 11, 2020	BUY	$38.5 - $76.05 $891,236 - $1.76 Million	23,149 Added 771.63%	26,149 $1.92 Million
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $71,802 - $141,833	1,865 Added 164.32%	3,000 $220,000
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $3,368 - $6,253	-100 Reduced 8.1%	1,135 $48,000
Q3 2019 Oct 29, 2019	BUY	$40.99 - $52.56 $50,622 - $64,911	1,235 New	1,235 $51,000

Others Institutions Holding CRSP

# of Institutions

484

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Account

Fin Trust Capital Advisors, LLC Crispr Therapeutics Ag Transaction History